TY - JOUR
T1 - Genetic analysis of sinonasal adenocarcinoma phenotypes
T2 - Distinct alterations of histogenetic significance
AU - Yom, Sue S.
AU - Rashid, Asif
AU - Rosenthal, David I.
AU - Elliott, Danielle D.
AU - Hanna, Ehab Y.
AU - Weber, Randal S.
AU - El-Naggar, Adel K.
N1 - Funding Information:
This work was supported in part by the Kenneth D Müller Professorship and a National Cancer Institute Specialized Program of Research Excellence grant in head and neck cancer.
PY - 2005/3
Y1 - 2005/3
N2 - Sinonasal adenocarcinomas, a relatively rare entity, are composed of distinctly different morphologic subtypes with variable biological behavior. To investigate the genetic events associated with their development and clinicopathologic features, we analyzed the alterations in K-ras, ARC, β-catenin, hMLH1 and hMSH2 and p53 genes expression in a cohort of 15 primary tumors comprising the two main sinonasal adenocarcinoma subtypes (enteric and seromucinous). The patients consisted to 13 men and two women, who ranged in age from 50 to 87 years. Tumors were predominantly located in the ethmoid sinus. Eight tumors were Enteric-type, and seven were seromucinous type. Nine patients were smokers and four were nonsmokers; and no information was available on two patients. Two of the eight enteric-type, had K-ras mutation at codons 12A and 12B, and one showed microsatellite instability at BAT-25. Two patients with enteric-type tumors had a history of wood-dust exposure, and one had a K-ras mutation at 12.4 codon as well as p53 overexpression. No patients with the seromucinous type had any genetic abnormalities, except for overexpression of p53 in two tumors. Our results show that (1) a subset of enteric-type sinonasal adenocarcinoma shares certain genetic alterations with colonic adenocarcinomas, (2) the seromucinous-type sinonasal adenocarcinoma lacks alterations and may develop through a different pathway, (3) high p53 expression is associated with aggressive tumor features in both subtypes and (4) the enteric-type runs a more malignant course than the seromucinous counterpart.
AB - Sinonasal adenocarcinomas, a relatively rare entity, are composed of distinctly different morphologic subtypes with variable biological behavior. To investigate the genetic events associated with their development and clinicopathologic features, we analyzed the alterations in K-ras, ARC, β-catenin, hMLH1 and hMSH2 and p53 genes expression in a cohort of 15 primary tumors comprising the two main sinonasal adenocarcinoma subtypes (enteric and seromucinous). The patients consisted to 13 men and two women, who ranged in age from 50 to 87 years. Tumors were predominantly located in the ethmoid sinus. Eight tumors were Enteric-type, and seven were seromucinous type. Nine patients were smokers and four were nonsmokers; and no information was available on two patients. Two of the eight enteric-type, had K-ras mutation at codons 12A and 12B, and one showed microsatellite instability at BAT-25. Two patients with enteric-type tumors had a history of wood-dust exposure, and one had a K-ras mutation at 12.4 codon as well as p53 overexpression. No patients with the seromucinous type had any genetic abnormalities, except for overexpression of p53 in two tumors. Our results show that (1) a subset of enteric-type sinonasal adenocarcinoma shares certain genetic alterations with colonic adenocarcinomas, (2) the seromucinous-type sinonasal adenocarcinoma lacks alterations and may develop through a different pathway, (3) high p53 expression is associated with aggressive tumor features in both subtypes and (4) the enteric-type runs a more malignant course than the seromucinous counterpart.
KW - Enteric-type adenocarcinoma
KW - Molecular analysis
KW - Seromucinous carcinoma
KW - Sinonasal adenocarcinoma
UR - http://www.scopus.com/inward/record.url?scp=15444378491&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=15444378491&partnerID=8YFLogxK
U2 - 10.1038/modpathol.3800315
DO - 10.1038/modpathol.3800315
M3 - Article
C2 - 15492756
AN - SCOPUS:15444378491
SN - 0893-3952
VL - 18
SP - 315
EP - 319
JO - Modern Pathology
JF - Modern Pathology
IS - 3
ER -